<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>10390682</id><passage><infon key="name_1">surname:Al-Naemi;given-names:Raed Salim</infon><infon key="name_0">surname:Abdal;given-names:Tareek Abdulqadir</infon><infon key="fpage">301</infon><infon key="issue">2</infon><infon key="year">2023</infon><infon key="article-id_doi">10.5455/javar.2023.j682</infon><infon key="type">front</infon><infon key="volume">10</infon><infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0)</infon><infon key="section_type">TITLE</infon><infon key="kwd">Osteopontin gene expression gallbladder stone cholelithiasis oxidative stress lithogenic diet</infon><infon key="lpage">307</infon><infon key="article-id_pmc">10390682</infon><infon key="article-id_pmid">37534080</infon><offset>0</offset><text>Osteopontin (SPP1) expression on gallstone formation in rabbits fed with a lithogenic diet</text><annotation id="521"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="0" length="11" /><text>Osteopontin</text></annotation><annotation id="522"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="13" length="4" /><text>SPP1</text></annotation><annotation id="523"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="33" length="19" /><text>gallstone formation</text></annotation><annotation id="524"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="56" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>91</offset><text>Objective:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>102</offset><text>This research was designed to assess the influence of the administration of a lithogenic diet, hydrogen peroxide, and vitamin AD3E on rabbits' gallstone formation and to envisage the expression of osteopontin (OPN) in their hepatic tissues.</text><annotation id="525"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="299" length="11" /><text>osteopontin</text></annotation><annotation id="526"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="312" length="3" /><text>OPN</text></annotation><annotation id="527"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="236" length="7" /><text>rabbits</text></annotation><annotation id="528"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="245" length="9" /><text>gallstone</text></annotation><annotation id="529"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="197" length="17" /><text>hydrogen peroxide</text></annotation><annotation id="530"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="220" length="12" /><text>vitamin AD3E</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>345</offset><text>Materials and Methods:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>368</offset><text>Twenty-four healthy local mature rabbits of both genders were divided into four equal groups. At the end of the feeding period, samples of blood were taken from all rabbits after they had fasted overnight to estimate the serum lipid profile. And some of the hepatic tissue has been preserved at -28 C for molecular analysis and gene expression.</text><annotation id="531"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="533" length="7" /><text>rabbits</text></annotation><annotation id="532"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="595" length="5" /><text>lipid</text></annotation><annotation id="533"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="401" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>716</offset><text>Results:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>725</offset><text>The gallstones were formed 100% in the GIII and 50% in the GIV. The mRNA OPN expression showed a significant increase in the GIII when compared with other groups. In Groups III and II, the serum levels of total cholesterol, Triglyceride, L-C, low-density lipoprotein-choles, and VLDL-C were significantly increased when compared with GI, while in GIII, the serum level of high-density lipoprotein-cholesterol was significantly decreased when compared with GI.</text><annotation id="534"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="798" length="3" /><text>OPN</text></annotation><annotation id="535"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="968" length="30" /><text>low-density lipoprotein-choles</text></annotation><annotation id="536"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="949" length="12" /><text>Triglyceride</text></annotation><annotation id="537"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="1004" length="6" /><text>VLDL-C</text></annotation><annotation id="538"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="729" length="10" /><text>gallstones</text></annotation><annotation id="539"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="936" length="11" /><text>cholesterol</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1185</offset><text>Conclusion:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1197</offset><text>It was concluded that the expression of the mRNA OPN was increased in the hepatic tissue of gallstone-formed rabbits.</text><annotation id="540"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1246" length="3" /><text>OPN</text></annotation><annotation id="541"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="1306" length="7" /><text>rabbits</text></annotation><annotation id="542"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="1289" length="9" /><text>gallstone</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1315</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1328</offset><text>In 1979, Osteopontin (OPN) was first noticed by Senger, and in 1985 was named by Franzen, OPN is a Latin word osteo means bone and pontin means Bridge, which has a relation with the lusty role of OPN in the body, sometimes OPN mentioned as an early T-lymphocyte activation protein 1, or secreted phosphoprotein 1 (SPP-1), OPN is encoded by SPP1 gene that is a multifunctional soluble cytokine and a matrix-related glycoprotein belongs to the small integrin-binding ligand N-linked glycoprotein, existing in some fluids of the body such as blood, urine, and milk, and a plurality of tissues and in many organs like gall bladder, kidney, lungs, breasts, brain, placenta, salivary and sweat glands, pancreas, inner ear, arteries, nerve cell, an immune cell, urinary and reproductive tracts, epithelial cells of the digestive system, OPN has participated in a different number of physiological processes including the organizing of bone formation/resorption, organizing of the immune system, brain and gut development, OPN has also a pathogenic role in atherosclerosis, tumorigenesis, metastasis, and liver inflammation and injury, it canchange the hepatic cholesterol metabolism thus participating in the pathogenesis of cholelithiasis in experimental animals, and because of its increased expression in the epithelium of intrahepatic bile stone-loaded ducts, it is closely related to hepatolithiasis. However, the mechanism and role of OPN in forming cholesterol gallstone (GS) are undetermined.</text><annotation id="543"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1337" length="11" /><text>Osteopontin</text></annotation><annotation id="544"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1350" length="3" /><text>OPN</text></annotation><annotation id="545"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1418" length="3" /><text>OPN</text></annotation><annotation id="546"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1524" length="3" /><text>OPN</text></annotation><annotation id="547"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1551" length="3" /><text>OPN</text></annotation><annotation id="548"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1615" length="25" /><text>secreted phosphoprotein 1</text></annotation><annotation id="549"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1642" length="5" /><text>SPP-1</text></annotation><annotation id="550"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1650" length="3" /><text>OPN</text></annotation><annotation id="551"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="1668" length="4" /><text>SPP1</text></annotation><annotation id="552"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="2158" length="3" /><text>OPN</text></annotation><annotation id="553"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="2343" length="3" /><text>OPN</text></annotation><annotation id="554"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="2762" length="3" /><text>OPN</text></annotation><annotation id="555"><infon key="identifier">MESH:D050197</infon><infon key="type">Disease</infon><location offset="2377" length="15" /><text>atherosclerosis</text></annotation><annotation id="556"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="2800" length="2" /><text>GS</text></annotation><annotation id="557"><infon key="identifier">MESH:D009362</infon><infon key="type">Disease</infon><location offset="2409" length="10" /><text>metastasis</text></annotation><annotation id="558"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="2481" length="11" /><text>cholesterol</text></annotation><annotation id="559"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="2777" length="21" /><text>cholesterol gallstone</text></annotation><annotation id="560"><infon key="type">Disease</infon><location offset="2710" length="15" /><text>hepatolithiasis</text></annotation><annotation id="561"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="2425" length="22" /><text>liver inflammation and</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2822</offset><text>Gallstone disease (GDs) is considered a great health issue worldwide because of its related complications and comorbidities. It has a large financial burden on the healthcare economy, and GDs are influenced by an interaction of complicated environmental and genetic factors. About 10%-15% of the global adult population is influenced by GDs because it is a highly prevalent gastroenterological disorder. It is not lethal, but it can result in severe GIT disorders leading to many serious complications and outcomes, such as pancreatitis, gallbladder cancer, and acute GSs. The pathogenesis and formation of cholesterol gallstone disease (CGD) have long been mysteries. It has been thought for many years that GD was due to an inflammatory disease of the gallbladder tissues (cholecystitis), which leads the cell to desquamate and produce abnormal materials. For the time being, the hepatic production of cholesterol-hypersaturated bile is considered a precondition and prerequisite for CGD. Depending on the major chemical ingredients, GSs are classified into three kinds: cholesterol GSs, pigmented GSs, and mixed GSs, and anatomically, GSs can be categorized as intrahepatic and extrahepatic bile duct stones. An imbalance between major bile ingredients, cholesterol, phospholipids, and bile salts, is considered the main factor resulting in GS formation. The supersaturation of bile and the precipitation of cholesterol are required when there is a shortage of salts or phospholipids and too much cholesterol or when there is a combination of these factors so that the homeostasis of cholesterol is important to stop the formation of GSs. Cholesterol homeostasis is maintained when there is an equilibrium between intake, biosynthesis, and biliary secretion of cholesterol.</text><annotation id="562"><infon key="identifier">MESH:D002764</infon><infon key="type">Disease</infon><location offset="3597" length="13" /><text>cholecystitis</text></annotation><annotation id="563"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="4322" length="11" /><text>cholesterol</text></annotation><annotation id="564"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="3159" length="3" /><text>GDs</text></annotation><annotation id="565"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="4166" length="2" /><text>GS</text></annotation><annotation id="566"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="3808" length="3" /><text>CGD</text></annotation><annotation id="567"><infon key="identifier">MESH:D001647</infon><infon key="type">Chemical</infon><location offset="4111" length="10" /><text>bile salts</text></annotation><annotation id="568"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="2841" length="3" /><text>GDs</text></annotation><annotation id="569"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="4079" length="11" /><text>cholesterol</text></annotation><annotation id="570"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="4586" length="11" /><text>cholesterol</text></annotation><annotation id="571"><infon key="identifier">MESH:D005705</infon><infon key="type">Disease</infon><location offset="3548" length="39" /><text>inflammatory disease of the gallbladder</text></annotation><annotation id="572"><infon key="identifier">MESH:D012492</infon><infon key="type">Chemical</infon><location offset="4286" length="5" /><text>salts</text></annotation><annotation id="573"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="4233" length="11" /><text>cholesterol</text></annotation><annotation id="574"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="2822" length="17" /><text>Gallstone disease</text></annotation><annotation id="575"><infon key="identifier">MESH:D010195</infon><infon key="type">Disease</infon><location offset="3346" length="12" /><text>pancreatitis</text></annotation><annotation id="576"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="3460" length="3" /><text>CGD</text></annotation><annotation id="577"><infon key="identifier">MESH:D001651</infon><infon key="type">Disease</infon><location offset="3986" length="46" /><text>intrahepatic and extrahepatic bile duct stones</text></annotation><annotation id="578"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="3726" length="11" /><text>cholesterol</text></annotation><annotation id="579"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="3010" length="3" /><text>GDs</text></annotation><annotation id="580"><infon key="type">Disease</infon><location offset="3907" length="3" /><text>GSs</text></annotation><annotation id="581"><infon key="identifier">MESH:D009358</infon><infon key="type">Disease</infon><location offset="3272" length="13" /><text>GIT disorders</text></annotation><annotation id="582"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="3895" length="11" /><text>cholesterol</text></annotation><annotation id="583"><infon key="type">Disease</infon><location offset="3390" length="3" /><text>GSs</text></annotation><annotation id="584"><infon key="identifier">MESH:D010743</infon><infon key="type">Chemical</infon><location offset="4092" length="13" /><text>phospholipids</text></annotation><annotation id="585"><infon key="type">Disease</infon><location offset="3922" length="3" /><text>GSs</text></annotation><annotation id="586"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="3429" length="29" /><text>cholesterol gallstone disease</text></annotation><annotation id="587"><infon key="type">Disease</infon><location offset="3960" length="3" /><text>GSs</text></annotation><annotation id="588"><infon key="type">Disease</infon><location offset="3858" length="3" /><text>GSs</text></annotation><annotation id="589"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="4464" length="11" /><text>Cholesterol</text></annotation><annotation id="590"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="4409" length="11" /><text>cholesterol</text></annotation><annotation id="591"><infon key="identifier">MESH:D005776</infon><infon key="type">Disease</infon><location offset="3531" length="2" /><text>GD</text></annotation><annotation id="592"><infon key="identifier">MESH:D005706</infon><infon key="type">Disease</infon><location offset="3360" length="18" /><text>gallbladder cancer</text></annotation><annotation id="593"><infon key="type">Disease</infon><location offset="3937" length="3" /><text>GSs</text></annotation><annotation id="594"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="4061" length="16" /><text>bile ingredients</text></annotation><annotation id="595"><infon key="identifier">MESH:D009358</infon><infon key="type">Disease</infon><location offset="3196" length="28" /><text>gastroenterological disorder</text></annotation><annotation id="596"><infon key="identifier">MESH:D010743</infon><infon key="type">Chemical</infon><location offset="4295" length="13" /><text>phospholipids</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4601</offset><text>Oxidative stress is determined as an unstable equilibrium between the free radical generation and the antioxidant capacity of the cells, causing potential cellular prejudice toward proteins, fat, nucleic acids, and carbohydrates. It has been studied since the 1970s, but its concept can be traced back to the 1950s. Free radicals are usually known as any chemical species that exist independently and are usually unstable and highly reactive chemical species due to the presence of one or more unpaired electrons in the outer orbitals; therefore, they are characterized by high reactivity in chemical reactions for electron exchange. There are two sorts of free radicals in the biological system, reactive oxygen species (ROS) and reactive nitrogen species, that are produced in the liver as a byproduct through the processes of metabolizing various compounds and also through a mitochondrial electron chain reaction. Hydrogen peroxide (H2O2) is capable of causing significant cellular damage even at low concentrations. Under normal physiological conditions, the body has enough antioxidant defense capacity and repair systems to recognize and remove molecules damaged by free radical oxidation. A mild degree of oxidative stress can be resisted by most body cells. The equilibrium between the elimination rate of free radicals by specific antioxidants and their generation rate is important, because impairment or limitation in the action of antioxidants and the excessive amounts of cellular free radicals production resulting in the excessive ROS generation can be harmful, which depletes the endogenous antioxidants that subsequently fail to counteract all the ROS, exerting deleterious effects on cell function because they are highly reactive with all biological substances such as proteins, nucleic acids, lipids, damaging proteins, DNA, and lipid peroxidation, and degradation of poly-unsaturated fatty acids occurs by ROS forming malondialdehyde, which is considered a reliable and popular biomarker to estimate and measure oxidative stress levels in an organism.</text><annotation id="597"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="6451" length="5" /><text>lipid</text></annotation><annotation id="598"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="6415" length="6" /><text>lipids</text></annotation><annotation id="599"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="4917" length="13" /><text>Free radicals</text></annotation><annotation id="600"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="5258" length="13" /><text>free radicals</text></annotation><annotation id="601"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="5538" length="4" /><text>H2O2</text></annotation><annotation id="602"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="5916" length="13" /><text>free radicals</text></annotation><annotation id="603"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="6267" length="3" /><text>ROS</text></annotation><annotation id="604"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="4671" length="12" /><text>free radical</text></annotation><annotation id="605"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="5774" length="12" /><text>free radical</text></annotation><annotation id="606"><infon key="identifier">MESH:D002241</infon><infon key="type">Chemical</infon><location offset="4816" length="13" /><text>carbohydrates</text></annotation><annotation id="607"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="6529" length="3" /><text>ROS</text></annotation><annotation id="608"><infon key="identifier">MESH:D008315</infon><infon key="type">Chemical</infon><location offset="6541" length="15" /><text>malondialdehyde</text></annotation><annotation id="609"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="6148" length="3" /><text>ROS</text></annotation><annotation id="610"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="5519" length="17" /><text>Hydrogen peroxide</text></annotation><annotation id="611"><infon key="identifier">MESH:D026361</infon><infon key="type">Chemical</infon><location offset="5332" length="25" /><text>reactive nitrogen species</text></annotation><annotation id="612"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="6490" length="28" /><text>poly-unsaturated fatty acids</text></annotation><annotation id="613"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="6096" length="13" /><text>free radicals</text></annotation><annotation id="614"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="5323" length="3" /><text>ROS</text></annotation><annotation id="615"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="5298" length="23" /><text>reactive oxygen species</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>6675</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6697</offset><text>Ethical approval</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6714</offset><text>In this research, all experimental works were approved by the Local Ethics Committee set up at the College of Veterinary Medicine, University of Duhok (No. CVM20190910UD).</text><annotation id="616"><infon key="type">Disease</infon><location offset="6870" length="13" /><text>CVM20190910UD</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6886</offset><text>Chemicals</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6896</offset><text>Dihydrocholesterol (Alfa Aesar Thermo Fisher, Scientific, Germany); H2O2 (Scharlab S.L., Gato Perez, Sentmenat, Spain). Vitamin AD3E injection (interchemie, Netherlands) total Ribonucleic acid (RNA) extraction kit supplied by ADD BIO-KOREA, complementary deoxyribonucleic acid (cDNA) supplied by ADD BIO-KOREA, SPP1 primer, and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primer (Macrogene/Korea).</text><annotation id="617"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="7207" length="4" /><text>SPP1</text></annotation><annotation id="618"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="7224" length="40" /><text>Glyceraldehyde-3-phosphate dehydrogenase</text></annotation><annotation id="619"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="7266" length="5" /><text>GAPDH</text></annotation><annotation id="620"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="6964" length="4" /><text>H2O2</text></annotation><annotation id="621"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="7016" length="12" /><text>Vitamin AD3E</text></annotation><annotation id="622"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="6896" length="18" /><text>Dihydrocholesterol</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7299</offset><text>Animals, diets, and treatment</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7329</offset><text>Twenty-four healthy local mature rabbits, regardless of sex, were used in this study, with weights between 1 and 1.5 kg. All rabbits were environmentally adapted in the animal holding room and kept under standard laboratory conditions for at least a week prior to the experiment; they were put in cages and fed with standard locally prepared diets with free access to tap water. Regarding their sex, they were divided into four equal groups, consisting of three males and three females separated from each other, and every individual rabbit was housed in a stainless steel cage. G1 (control group): rabbits in this group did not receive any medications; they were fed a standard rabbit diet and water for 6 weeks. GII (H2O2 group): in this group, rabbits were administered 1% H2O2 with their drinking water, which was prepared daily in a dark bottle, and a normal diet for 6 weeks. GIII (lithogenic group), in addition to 1% H2O2 in their drinking water, was fed a lithogenic diet (LD) consisting of 1% dihydrocholesterol, which begins at the start of the 4th week and continues until the end of the 6th week for the induction of GSs. In the GIV (Vit. AD3E group), in this group, the same treatments were as in GIII except for stopping 1% H2O2 administration. The rabbits were also injected with 0.1 ml of vitamin AD3E twice weekly from the start of the 4th week and continued till the end of the 6th week to prevent or reduce gallstone occurrences.</text><annotation id="623"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="8254" length="4" /><text>H2O2</text></annotation><annotation id="624"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="8568" length="4" /><text>H2O2</text></annotation><annotation id="625"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="8635" length="12" /><text>vitamin AD3E</text></annotation><annotation id="626"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="8593" length="7" /><text>rabbits</text></annotation><annotation id="627"><infon key="identifier">MESH:D014867</infon><infon key="type">Chemical</infon><location offset="8130" length="5" /><text>water</text></annotation><annotation id="628"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="8105" length="4" /><text>H2O2</text></annotation><annotation id="629"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="8048" length="4" /><text>H2O2</text></annotation><annotation id="630"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="8332" length="18" /><text>dihydrocholesterol</text></annotation><annotation id="631"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="8008" length="6" /><text>rabbit</text></annotation><annotation id="632"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="8076" length="7" /><text>rabbits</text></annotation><annotation id="633"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="8481" length="4" /><text>AD3E</text></annotation><annotation id="634"><infon key="identifier">MESH:D014867</infon><infon key="type">Chemical</infon><location offset="8277" length="5" /><text>water</text></annotation><annotation id="635"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="7362" length="7" /><text>rabbits</text></annotation><annotation id="636"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="7908" length="2" /><text>G1</text></annotation><annotation id="637"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="7928" length="7" /><text>rabbits</text></annotation><annotation id="638"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="7454" length="7" /><text>rabbits</text></annotation><annotation id="639"><infon key="identifier">MESH:D014867</infon><infon key="type">Chemical</infon><location offset="8024" length="5" /><text>water</text></annotation><annotation id="640"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="7863" length="6" /><text>rabbit</text></annotation><annotation id="641"><infon key="identifier">MESH:D014867</infon><infon key="type">Chemical</infon><location offset="7701" length="5" /><text>water</text></annotation><annotation id="642"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="8756" length="9" /><text>gallstone</text></annotation><annotation id="643"><infon key="type">Disease</infon><location offset="8459" length="3" /><text>GSs</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8779</offset><text>A sampling of the blood and hepatic tissues</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8823</offset><text>According to the ethical guidelines that were approved by the American Veterinary Medical Association, all animals are euthanized before killing. After an overnight fast, blood was immediately and directly drawn from the heart into a heparinized test tube at the end of the feeding period (6 weeks). By centrifuging the blood at 3,500 rpm for 20 min, the isolation of serum was done. The separated serum samples were immediately put in an Eppendorf tube and stored at -20 C for measurement of biochemical parameters. All rabbits were sacrificed, and an immediate autopsy was performed for each rabbit in order to obtain the stone, hepatic, and gallbladder samples. A cholecystectomy was performed, and each gallbladder was cleaned trimmed of extraneous tissue, and washed with normal saline, and the bile was withdrawn by a sterile disposable syringe in all rabbits in the GIII. It is difficult to withdraw their bile because their gallbladder is filled with stones (Fig. 1B). After the bile has been drawn, each gallbladder has been opened to notice the GSs. A piece of the gallbladder has been put on a slide to take an immediate image showing the gallbladder tissues and the presence of any remaining GSs under a different magnification lens (Fig. 2A-D) and some of the hepatic tissue has been preserved at -28 C for molecular analysis and gene expression.</text><annotation id="644"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="9344" length="7" /><text>rabbits</text></annotation><annotation id="645"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="9681" length="7" /><text>rabbits</text></annotation><annotation id="646"><infon key="identifier">MESH:D007669</infon><infon key="type">Disease</infon><location offset="9447" length="5" /><text>stone</text></annotation><annotation id="647"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="9417" length="6" /><text>rabbit</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10191</offset><text>Serum lipid profile</text><annotation id="648"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="10197" length="5" /><text>lipid</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10211</offset><text>A standard commercial kit provided by Roche (USA): Serum total cholesterol (TC): REF: 03039773; serum Triglyceride (TG): REF: 20767107 322. Serum low-density lipoprotein-cholesterol (REF: 03038866) and serum high-density lipoprotein-cholesterol (REF: 07528566) were used to estimate the lipid profile.</text><annotation id="649"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="10287" length="2" /><text>TC</text></annotation><annotation id="650"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="10274" length="11" /><text>cholesterol</text></annotation><annotation id="651"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="10498" length="5" /><text>lipid</text></annotation><annotation id="652"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="10313" length="12" /><text>Triglyceride</text></annotation><annotation id="653"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="10327" length="2" /><text>TG</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10513</offset><text>Quantitative real-time reverse transcription-polymerized chain reaction (PCR) analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10600</offset><text>According to the instructions of the company, the total RNA from 50 mg of frozen hepatic tissue was extracted using the total RNA extraction kit supplied by ADD BIO-KOREA. 2 mul of total RNA was used to generate first-strand complementary DNA (cDNA) with ADD BIO-KOREA. Subsequently, 5 mul of cDNA product was used for PCR to amplify OPN with the corresponding primers, SPP1: 5'-TCT CCT AAC ACC GCA GAA TG -3' (Forward) and 5'-TCT GTA AGC CAC ACT GTC AC-3' (Reverse), GAPDH: 5'-GGC GTG AAC CAC GAG AAG TA-3' (Forward) and 5'-TCC ACA ATG CCG AAG TGG TC-3' (Reverse). The Amplicon sizes of PCR products were 310 and 116 bp, respectively. The temperature cycling protocol consisted of 1 cycle of a preheating step (95 C for 5 min), 1 cycle of denaturation (94 C for 45 sec), 30 cycles of annealing (55 C for 45 sec), and 1 cycle of extension (72 C for 45 sec). A final extension step (72 C for 5 min) was also carried out. Experiments were performed in duplicate, and normalized mRNA expression was done by GAPDH. In a 1% agarose gel, the separation of the PCR products occurred. The band intensity was quantified by ImageJ Software. Using ImageJ Software, the intensification of the SPP1 gene band was normalized with that of the reference gene GAPDH.</text><annotation id="654"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="10934" length="3" /><text>OPN</text></annotation><annotation id="655"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="10970" length="4" /><text>SPP1</text></annotation><annotation id="656"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="11068" length="5" /><text>GAPDH</text></annotation><annotation id="657"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="11604" length="5" /><text>GAPDH</text></annotation><annotation id="658"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="11781" length="4" /><text>SPP1</text></annotation><annotation id="659"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="11843" length="5" /><text>GAPDH</text></annotation><annotation id="660"><infon key="identifier">MESH:D012685</infon><infon key="type">Chemical</infon><location offset="11619" length="7" /><text>agarose</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>11871</offset><text>Statistical analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11892</offset><text>All statistical analyses were performed using one-way analysis of variance, and differences between groups were estimated using Duncan multiple range tests using version 23 of SPSS. The results were expressed as the mean +- standard error of the mean of six rabbits per group. At p &lt; 0.05 difference between the two groups was accepted.</text><annotation id="661"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="12150" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>12229</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>12237</offset><text>The mRNA expression of SPP1 in rabbits' hepatic tissue</text><annotation id="662"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="12260" length="4" /><text>SPP1</text></annotation><annotation id="663"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="12268" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12294</offset><text>The PCR products for OPN (SPP1) amplification and GAPDH were (310 and 116) bp, respectively; the amplified levels of the mRNAs of SPP1 in hepatic tissues in the group that was fed an LD and exposed to H2O2 were increased but markedly decreased in the control group (Fig. 3). The mRNA OPN expression in the GIII was significantly increased when compared with other groups; the mean values +- SE of the GIII, GI, GII, and GIV, respectively, were (153.09 +- 4.009), (89.41 +- 0.58), (117.19 +- 9.11), and (111.08 +- 4.97). There is an insignificant increase in mRNA OPN expression in GII compared with GIV; the mean values +- SE of GII and GIV were (117.19 +- 9.11) and (111.08 +- 4.97). However, a significant increase in mRNA OPN expression was found in GII and GIV when compared with GI; the mean values +- SE of the GII, GIV, and GI were (117.19 +- 9.11), (111.08 +- 4.97), and (89.41 +- 0.58).</text><annotation id="664"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="12315" length="3" /><text>OPN</text></annotation><annotation id="665"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="12320" length="4" /><text>SPP1</text></annotation><annotation id="666"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="12344" length="5" /><text>GAPDH</text></annotation><annotation id="667"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="12424" length="4" /><text>SPP1</text></annotation><annotation id="668"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="12578" length="3" /><text>OPN</text></annotation><annotation id="669"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="12857" length="3" /><text>OPN</text></annotation><annotation id="670"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="13019" length="3" /><text>OPN</text></annotation><annotation id="671"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="12495" length="4" /><text>H2O2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JAVAR-10-301-g001.jpg</infon><infon key="id">figure1</infon><infon key="type">fig_title_caption</infon><offset>13190</offset><text>Induced gallbladder stone formation experimentally in rabbits. A = normal gallbladder in the GI. B and C show the induction of GSs in GIII. D shows partial recovery from stone formation in GIV.</text><annotation id="672"><infon key="identifier">MESH:D058426</infon><infon key="type">Disease</infon><location offset="13360" length="15" /><text>stone formation</text></annotation><annotation id="673"><infon key="identifier">MESH:D005705</infon><infon key="type">Disease</infon><location offset="13198" length="27" /><text>gallbladder stone formation</text></annotation><annotation id="674"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="13244" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13384</offset><text>Rate of gallstone formation in rabbits</text><annotation id="675"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="13392" length="19" /><text>gallstone formation</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13423</offset><text>GSs were not found in the gallbladder in any rabbits of the group's GI and GII fed with a standard rabbit diet (Table 1). However, 100% and 50% of cholesterol GS were found in the gallbladders of rabbits in GIII and GV1, respectively, regardless of their sex, which considered the experimental groups fed with dihydrocholesterol for 3 weeks.</text><annotation id="676"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="13619" length="7" /><text>rabbits</text></annotation><annotation id="677"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="13522" length="6" /><text>rabbit</text></annotation><annotation id="678"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="13733" length="18" /><text>dihydrocholesterol</text></annotation><annotation id="679"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="13570" length="11" /><text>cholesterol</text></annotation><annotation id="680"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="13468" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JAVAR-10-301-g002.jpg</infon><infon key="id">figure2</infon><infon key="type">fig_title_caption</infon><offset>13767</offset><text>Microscopic appearance under two magnifications power (4 and 10x) of the opened gallbladder cyst filled with stones of two rabbits in GIII (number D1 and D2). *D = Dihydrocholesterol.</text><annotation id="681"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="13931" length="18" /><text>Dihydrocholesterol</text></annotation><annotation id="682"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="13890" length="7" /><text>rabbits</text></annotation><annotation id="683"><infon key="identifier">MESH:D005705</infon><infon key="type">Disease</infon><location offset="13847" length="16" /><text>gallbladder cyst</text></annotation><annotation id="684"><infon key="identifier">MESH:D003903</infon><infon key="type">Chemical</infon><location offset="13927" length="1" /><text>D</text></annotation><annotation id="685"><infon key="identifier">tmVar:p|Allele|D|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="13914" length="2" /><text>D1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13952</offset><text>Analysis of serum lipid profile</text><annotation id="686"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="13970" length="5" /><text>lipid</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13984</offset><text>In the current study, the serum TC level was significantly increased in both GIII and GII when compared with G1; the mean values +- SE of serum TC levels of GIII, GII, and G1 were (112.8 +- 11.36), (99.60 +- 6.20), and (58.60 +- 2.65), respectively. While the serum TC level in G1V was insignificantly increased when compared with G1, the mean values +- SE of serum TC levels in G IV and G1 were (72.20 +- 7.996) and (58.60 +- 2.65), respectively (Table 2).</text><annotation id="687"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14372" length="2" /><text>G1</text></annotation><annotation id="688"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="14128" length="2" /><text>TC</text></annotation><annotation id="689"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="14250" length="2" /><text>TC</text></annotation><annotation id="690"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="14350" length="2" /><text>TC</text></annotation><annotation id="691"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="14016" length="2" /><text>TC</text></annotation><annotation id="692"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14262" length="2" /><text>G1</text></annotation><annotation id="693"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14315" length="2" /><text>G1</text></annotation><annotation id="694"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14156" length="2" /><text>G1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14442</offset><text>The serum TG level was significantly increased in groups GIII and GII when compared with G1; the mean values +- SE of serum TG levels of groups GIII, GII, and G1 were (127.6 +- 14.93), (104.6 +- 7.73), and (57.80 +- 9.906), respectively, while in G IV there was an insignificant increase in serum TG level when compared with G1. The mean values +- SE of serum TG levels of groups G IV and G1 were (77.80 +- 4.55) and (57.80 +- 9.906), respectively (Table 2).</text><annotation id="695"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="14452" length="2" /><text>TG</text></annotation><annotation id="696"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="14802" length="2" /><text>TG</text></annotation><annotation id="697"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14831" length="2" /><text>G1</text></annotation><annotation id="698"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14531" length="2" /><text>G1</text></annotation><annotation id="699"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="14566" length="2" /><text>TG</text></annotation><annotation id="700"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="14739" length="2" /><text>TG</text></annotation><annotation id="701"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14601" length="2" /><text>G1</text></annotation><annotation id="702"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="14767" length="2" /><text>G1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14901</offset><text>The serum high-density lipoprotein-cholesterol (HDL-C) level was significantly lower in GIII compared with G1; the mean values +- SE of serum HDL-C in GIII and G1 were (26.0 +- 2.529) and (34.20 +- 3.99), respectively. There was an insignificant decrease in serum HDL-C in both groups GII and GIV when compared with G1; the mean values +- SE of serum HDL-C in GII, GIV, and G1 were (29.40 +- 1.20), (30.60 +- 0.509), and (34.20 +- 3.99), respectively (Table 2).</text><annotation id="703"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15061" length="2" /><text>G1</text></annotation><annotation id="704"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15217" length="2" /><text>G1</text></annotation><annotation id="705"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15008" length="2" /><text>G1</text></annotation><annotation id="706"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15275" length="2" /><text>G1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15363</offset><text>The serum low-density lipoprotein-cholesterol (LDL-C) level in all treated groups was significantly increased when compared to G1; the mean values +- SE of serum of groups GII, GIII, GIV, and G1 were (71.20 +- 16.67), (87.80 +- 9.759), (74.40 +- 9.479), and (18.20 +- 0.734), respectively (Table 2).</text><annotation id="707"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15555" length="2" /><text>G1</text></annotation><annotation id="708"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15490" length="2" /><text>G1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15663</offset><text>The serum VLDL-C levels in groups GII, GIII, and GIV were significantly higher when compared with G1; the mean values +- SE of serum VLDL-C levels in GII, GIII, GIV, and G1 were (26.80 +- 1.28), (29.80 +- 2.90), (20.40 +- 1.469), and (13.40 +- 1.43), respectively (Table 2).</text><annotation id="709"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="15796" length="6" /><text>VLDL-C</text></annotation><annotation id="710"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="15673" length="6" /><text>VLDL-C</text></annotation><annotation id="711"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15833" length="2" /><text>G1</text></annotation><annotation id="712"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="15761" length="2" /><text>G1</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JAVAR-10-301-g003.jpg</infon><infon key="id">figure3</infon><infon key="type">fig_title_caption</infon><offset>15938</offset><text>Effect of H2O2, dihydro cholesterol, and vitamin AD3E administration on SPP1 mRNA expression in the hepatic tissue using GAPDH as an internal control.</text><annotation id="713"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="16010" length="4" /><text>SPP1</text></annotation><annotation id="714"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="16059" length="5" /><text>GAPDH</text></annotation><annotation id="715"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="15948" length="4" /><text>H2O2</text></annotation><annotation id="716"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="15979" length="12" /><text>vitamin AD3E</text></annotation><annotation id="717"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="15954" length="19" /><text>dihydro cholesterol</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16089</offset><text>The serum level of serum TC/HDL ratio was significantly increased in both G11 and GIII when compared with G1; the mean values +- SE of serum cholesterol/HDL levels of GII, GIII, and G1 were (3.38 +- .288), (4.33 +- .279), and (1.82 +- .338), respectively. While the serum level of TC/HDL ratio in G IV was insignificantly increased when compared with GI, the mean values +- SE of serum TC/HDL levels in G IV and GI were (2.416 +- 0.311) and (1.82 +- 0.338), respectively (Table 2). The serum level of LDL/HDL ratio in all treated groups GII, GIII, and G1V was significantly increased when compared with G1; the mean values +- SE of serum LDL/HDL ratio in GII, GIII, G1V, and GI were (2.60 +- 0.558), (3.558 +- 0.500), (2.172 +- 0.2406), and (0.572 +- 0.102), respectively (Table 2).</text><annotation id="718"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="16370" length="2" /><text>TC</text></annotation><annotation id="719"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="16114" length="2" /><text>TC</text></annotation><annotation id="720"><infon key="identifier">tmVar:p|SUB|G|1|V;HGVS:p.G1V;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="16755" length="3" /><text>G1V</text></annotation><annotation id="721"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="16230" length="11" /><text>cholesterol</text></annotation><annotation id="722"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="16692" length="2" /><text>G1</text></annotation><annotation id="723"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="16641" length="2" /><text>G1</text></annotation><annotation id="724"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="16475" length="2" /><text>TC</text></annotation><annotation id="725"><infon key="identifier">tmVar:c|Allele|G|1;VariantGroup:0;OriginalGene:100009074;CorrespondingGene:2597;CorrespondingSpecies:9986</infon><infon key="type">ProteinMutation</infon><location offset="16271" length="2" /><text>G1</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>16872</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16883</offset><text>The cholesterol gallstone pathogenesis is considered multifactorial, and though OPN has been found in normal humans' gallbladder bile and tissue, the role of OPN in forming GSs is still unknown. In the current study, there is a relatively higher detection of mRNA OPN expression in hepatic tissue in the GIII when compared with the GII, GIV, and GI. Also, when comparing the GII, GIV, and GI, there is an increase in the mRNA OPN expression in their hepatic tissues. The results reported by Jin et al. and Lin et al. agreed with our data and suggested that hepatic mRNA OPN expression was significantly higher in the GSDs group than in GI. Whereas the results of the study by Yang et al. disagreed with our data, which mentioned that protein and mRNA OPN expression was higher in normal tissue than in lithogenic gallbladder tissue.</text><annotation id="726"><infon key="identifier">6696</infon><infon key="type">Gene</infon><location offset="16963" length="3" /><text>OPN</text></annotation><annotation id="727"><infon key="identifier">6696</infon><infon key="type">Gene</infon><location offset="17041" length="3" /><text>OPN</text></annotation><annotation id="728"><infon key="identifier">6696</infon><infon key="type">Gene</infon><location offset="17147" length="3" /><text>OPN</text></annotation><annotation id="729"><infon key="identifier">6696</infon><infon key="type">Gene</infon><location offset="17309" length="3" /><text>OPN</text></annotation><annotation id="730"><infon key="identifier">6696</infon><infon key="type">Gene</infon><location offset="17453" length="3" /><text>OPN</text></annotation><annotation id="731"><infon key="identifier">6696</infon><infon key="type">Gene</infon><location offset="17634" length="3" /><text>OPN</text></annotation><annotation id="732"><infon key="identifier">MESH:C536176</infon><infon key="type">Disease</infon><location offset="17500" length="4" /><text>GSDs</text></annotation><annotation id="733"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="16992" length="6" /><text>humans</text></annotation><annotation id="734"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="16887" length="21" /><text>cholesterol gallstone</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">table1.xml</infon><infon key="id">table1</infon><infon key="type">table_title_caption</infon><offset>17718</offset><text>Rate of gallstone formation in rabbits.</text><annotation id="735"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="17726" length="19" /><text>gallstone formation</text></annotation><annotation id="736"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="17749" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">table1.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="rows"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th rowspan="1" colspan="1"&gt;Groups &lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;Number of gallstone in rabbits&lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;Number of gallstone rabbit&lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;Rate of gallstone formation (%)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;Control G.&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;6&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;0&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;G&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;6&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;0&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;Dihydrocholesterol G+ H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;G&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;6&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;6&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;100&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;Dihydrocholesterol+ vitamin AD3E G.&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;6&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;3&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;50&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">table1</infon><infon key="type">table</infon><offset>17758</offset><text>Groups 	Number of gallstone in rabbits	Number of gallstone rabbit	Rate of gallstone formation (%)	 	Control G.	6	0	0	 	H2O2G	6	0	0	 	Dihydrocholesterol G+ H2O2G	6	6	100	 	Dihydrocholesterol+ vitamin AD3E G.	6	3	50	 	</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">table2.xml</infon><infon key="id">table2</infon><infon key="type">table_title_caption</infon><offset>17975</offset><text>The mean +- SE of lipid profile in the four experimental groups.</text><annotation id="737"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="17993" length="5" /><text>lipid</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">table2.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="rows"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th rowspan="1" colspan="1"&gt;Parameter mg/dl&lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;GI&lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;GII&lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;GIII&lt;/th&gt;&lt;th rowspan="1" colspan="1"&gt;G IV&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;S. TC&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;58.60 +- 2.6&lt;sup&gt;5&lt;/sup&gt;b&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;99.60 +- 6.20&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;112.8 +- 11.36&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;72.20 +- 7.996&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;S. TG &lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;57.80 +- 9.906&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;104.6 +- 7.7&lt;sup&gt;3a,&lt;/sup&gt;b&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;127.6 +- 14.9&lt;sup&gt;3&lt;/sup&gt;a&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;77.80 +- 4.55&lt;sup&gt;c,b&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;S. HDL-C&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;34.20 +- 3.99&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;29.40 +- 1.20&lt;sup&gt;a,b&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;26.0 +- 2.52&lt;sup&gt;9&lt;/sup&gt;b&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;30.60 +- 0.509&lt;sup&gt;a,b&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;S.LDL-C &lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;18.20 +- 0.734&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;71.20 +- 16.67&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;87.80 +- 9.759&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;74.40 +- 9.479&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;S. VLDL-C &lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;13.40 +- 1.4&lt;sup&gt;3&lt;/sup&gt;c&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;26.80 +- 1.28&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;29.80 +- 2.90&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;20.40 +- 1.469&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;TC/HDL ratio&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;1.82 +- 0.33&lt;sup&gt;8&lt;/sup&gt;c&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;3.38 +- 0.288&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;4.33 +- 0.27&lt;sup&gt;9&lt;/sup&gt;a&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;2.416 +- 0.311&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="1" colspan="1"&gt;LDL/HDL ratio&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;0.572 +- 0.102&lt;sup&gt;c&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;2.60 +- 0.558&lt;sup&gt;a,b&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;3.558 +- 0.500&lt;sup&gt;a&lt;/sup&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;2.172 +- 0.2406&lt;sup&gt;b&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">table2</infon><infon key="type">table</infon><offset>18040</offset><text>Parameter mg/dl	GI	GII	GIII	G IV	 	S. TC	58.60 +- 2.65b	99.60 +- 6.20a	112.8 +- 11.36a	72.20 +- 7.996b	 	S. TG 	57.80 +- 9.906c	104.6 +- 7.73a,b	127.6 +- 14.93a	77.80 +- 4.55c,b	 	S. HDL-C	34.20 +- 3.99a	29.40 +- 1.20a,b	26.0 +- 2.529b	30.60 +- 0.509a,b	 	S.LDL-C 	18.20 +- 0.734b	71.20 +- 16.67a	87.80 +- 9.759a	74.40 +- 9.479a	 	S. VLDL-C 	13.40 +- 1.43c	26.80 +- 1.28a	29.80 +- 2.90a	20.40 +- 1.469b	 	TC/HDL ratio	1.82 +- 0.338c	3.38 +- 0.288b	4.33 +- 0.279a	2.416 +- 0.311c	 	LDL/HDL ratio	0.572 +- 0.102c	2.60 +- 0.558a,b	3.558 +- 0.500a	2.172 +- 0.2406b	 	</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">table2.xml</infon><infon key="id">table2</infon><infon key="type">table_foot</infon><offset>18604</offset><text>*Different and same letters among groups in a row pointed to statistically significant and insignificant differences at p &lt;= 0.05, respectively.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18750</offset><text>In this study, we added 1% dihydrocholesterol to the diet to induce cholesterol GSs. The rate of gallstone formation was 100% in the GIII when fed with 1% dihydrocholesterol for 21 days. While in the GIV, in addition to the administration of 1% dihydrocholesterol, we injected the rabbit with 0.1 ml of AD3E vitamins twice weekly to prevent or reduce the rate of GSs formation; therefore, the rate of GSs formation was 50% in the GIV. The results of Cui et al. agree with ours, who mentioned in their study that the rate of GSs formation was 100%. In rabbits, when fed, a diet contains high cholesterol for more than 4 weeks. The prevalence of GSs formation in both males and females was similar in GIII, in which rabbits feeding on an LD (three of three females and three of three males) developed GSs. The results of Lin et al. were consistent with our results; they mentioned in their study that the formation of GSs was the same in both genders; eighty percent of four out of five males and four out of five females of mice developed GSs when fed on an LD for 3 weeks when compared with the mice that fed on a normal diet.</text><annotation id="738"><infon key="type">Disease</infon><location offset="19394" length="3" /><text>GSs</text></annotation><annotation id="739"><infon key="type">Disease</infon><location offset="18830" length="3" /><text>GSs</text></annotation><annotation id="740"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="18777" length="18" /><text>dihydrocholesterol</text></annotation><annotation id="741"><infon key="type">Disease</infon><location offset="19666" length="3" /><text>GSs</text></annotation><annotation id="742"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="18847" length="9" /><text>gallstone</text></annotation><annotation id="743"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="18818" length="11" /><text>cholesterol</text></annotation><annotation id="744"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="18905" length="18" /><text>dihydrocholesterol</text></annotation><annotation id="745"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19053" length="13" /><text>AD3E vitamins</text></annotation><annotation id="746"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="19464" length="7" /><text>rabbits</text></annotation><annotation id="747"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="19845" length="4" /><text>mice</text></annotation><annotation id="748"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="19773" length="4" /><text>mice</text></annotation><annotation id="749"><infon key="identifier">MESH:D004083</infon><infon key="type">Chemical</infon><location offset="18995" length="18" /><text>dihydrocholesterol</text></annotation><annotation id="750"><infon key="type">Disease</infon><location offset="19274" length="3" /><text>GSs</text></annotation><annotation id="751"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="19301" length="7" /><text>rabbits</text></annotation><annotation id="752"><infon key="type">Disease</infon><location offset="19549" length="3" /><text>GSs</text></annotation><annotation id="753"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="19341" length="11" /><text>cholesterol</text></annotation><annotation id="754"><infon key="type">Disease</infon><location offset="19788" length="3" /><text>GSs</text></annotation><annotation id="755"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="19031" length="6" /><text>rabbit</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19877</offset><text>In our results, we found a positive relationship between GS formation and serum lipid profile; GSs formation is proportional to hyperlipidemia, and the same finding was reported by Chen and Wu, and Atamer et al. found a positive relation between GSDs and hyperlipidemia, which means that there were significantly high levels in the serum of TG, TC, and LDL-C in the GS group, while there were significantly low levels in the serum of HDL-C in the GS group when compared with the normal control group.</text><annotation id="756"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="20324" length="2" /><text>GS</text></annotation><annotation id="757"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="19957" length="5" /><text>lipid</text></annotation><annotation id="758"><infon key="identifier">MESH:D006949</infon><infon key="type">Disease</infon><location offset="20132" length="14" /><text>hyperlipidemia</text></annotation><annotation id="759"><infon key="identifier">MESH:D006949</infon><infon key="type">Disease</infon><location offset="20005" length="14" /><text>hyperlipidemia</text></annotation><annotation id="760"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="20222" length="2" /><text>TC</text></annotation><annotation id="761"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="20243" length="2" /><text>GS</text></annotation><annotation id="762"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="20218" length="2" /><text>TG</text></annotation><annotation id="763"><infon key="identifier">MESH:C536176</infon><infon key="type">Disease</infon><location offset="20123" length="4" /><text>GSDs</text></annotation></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>20378</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>20389</offset><text>It was concluded that when the rabbits were fed a high- cholesterol diet and exposed to H2O2, the incidence of gallstone formations reached a peak, and OPN mRNA expression was highly increased in their hepatic tissue, which proves that OPN is closely related to cholelithiasis and plays a significant role in the pathogenesis of GDs.</text><annotation id="764"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="20541" length="3" /><text>OPN</text></annotation><annotation id="765"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="20625" length="3" /><text>OPN</text></annotation><annotation id="766"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="20477" length="4" /><text>H2O2</text></annotation><annotation id="767"><infon key="identifier">MESH:D042882</infon><infon key="type">Disease</infon><location offset="20500" length="20" /><text>gallstone formations</text></annotation><annotation id="768"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="20445" length="11" /><text>cholesterol</text></annotation><annotation id="769"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="20718" length="3" /><text>GDs</text></annotation><annotation id="770"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="20651" length="14" /><text>cholelithiasis</text></annotation><annotation id="771"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="20420" length="7" /><text>rabbits</text></annotation></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title_1</infon><offset>20723</offset><text>List of abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>20745</offset><text>cDNA, Complementary deoxyribonucleic acid; CGDs, cholesterol gallstone disease; DNA, Deoxyribonucleic acid; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; GDs, Gallstone disease; GIT, gastrointestinal tract; H2O2, Hydrogen peroxide; HDL-C, High-density lipoprotein-cholesterol; LD, Lithogenic diet; LDL-C, low-density lipoprotein-cholesterol; OPN, Osteopontin; RNA, Ribonucleic acid; ROS, Reactive oxygen species; RT-PCR, Reverse transcription-polymerized chain reaction; SPP1, Secreted phosphoprotein 1; TC, Total cholesterol; TG, Triglyceride.</text><annotation id="772"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="20853" length="5" /><text>GAPDH</text></annotation><annotation id="773"><infon key="identifier">100009074</infon><infon key="type">Gene</infon><location offset="20860" length="40" /><text>Glyceraldehyde-3-phosphate dehydrogenase</text></annotation><annotation id="774"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21090" length="3" /><text>OPN</text></annotation><annotation id="775"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21095" length="11" /><text>Osteopontin</text></annotation><annotation id="776"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21219" length="4" /><text>SPP1</text></annotation><annotation id="777"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21225" length="25" /><text>Secreted phosphoprotein 1</text></annotation><annotation id="778"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="20902" length="3" /><text>GDs</text></annotation><annotation id="779"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="20794" length="29" /><text>cholesterol gallstone disease</text></annotation><annotation id="780"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="20955" length="4" /><text>H2O2</text></annotation><annotation id="781"><infon key="identifier">MESH:D002769</infon><infon key="type">Disease</infon><location offset="20907" length="17" /><text>Gallstone disease</text></annotation><annotation id="782"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="21279" length="12" /><text>Triglyceride</text></annotation><annotation id="783"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="21252" length="2" /><text>TC</text></annotation><annotation id="784"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="21136" length="23" /><text>Reactive oxygen species</text></annotation><annotation id="785"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="21275" length="2" /><text>TG</text></annotation><annotation id="786"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="21262" length="11" /><text>cholesterol</text></annotation><annotation id="787"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="21131" length="3" /><text>ROS</text></annotation><annotation id="788"><infon key="identifier">MESH:D006861</infon><infon key="type">Chemical</infon><location offset="20961" length="17" /><text>Hydrogen peroxide</text></annotation></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>21293</offset><text>Conflict of interest</text><annotation id="789"><infon key="type">Disease</infon><location offset="21293" length="11" /><text>Conflict of</text></annotation></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>21314</offset><text>There are no conflicts.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>21338</offset><text>Authors' contributions </text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>21364</offset><text>Al-Naemi RS contributed to conceiving and planning the experiments as a senior supervisor for this article (part of the Ph.D. project). Abdal TA carried out the implementation of the research lab work, sample collection, preparation, and different variable measurements. Abdal TA and Al-Naemi RS contribute to the analysis of the results and the writing of the manuscript.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>21737</offset><text>References</text></passage><passage><infon key="name_3">surname:Wang;given-names:B</infon><infon key="name_2">surname:Zhang;given-names:D</infon><infon key="name_1">surname:Wang;given-names:CH</infon><infon key="name_0">surname:Si;given-names:J</infon><infon key="fpage">e919159</infon><infon key="pub-id_pmid">31996665</infon><infon key="year">2020</infon><infon key="source">Med Sci Monit</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="section_type">REF</infon><infon key="comment">http://dx.doi.org/10.12659/MSM.919159</infon><infon key="name_5">surname:Zhou;given-names:Y</infon><infon key="name_4">surname:Hou;given-names:W</infon><offset>21748</offset><text>Osteopontinin bone metabolism and bone diseases</text></passage><passage><infon key="name_3">surname:Dusza;given-names:M</infon><infon key="name_2">surname:Ochrem;given-names:A</infon><infon key="name_1">surname:Pokorska;given-names:J</infon><infon key="name_0">surname:Kulaj;given-names:D</infon><infon key="fpage">546</infon><infon key="issue">1</infon><infon key="year">2019</infon><infon key="source">Italian J Anim Sci</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1080/1828051X.2018.1547129</infon><infon key="lpage">53</infon><infon key="name_4">surname:Makulska;given-names:J</infon><offset>21796</offset><text>Effects of the c.8514C &gt; T polymorphism in the osteopontin gene (OPN) on milk production, milk composition and disease susceptibility in Holstein Friesian cattle</text><annotation id="790"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21843" length="11" /><text>osteopontin</text></annotation><annotation id="791"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21861" length="3" /><text>OPN</text></annotation><annotation id="792"><infon key="identifier">tmVar:c|SUB|C|8514|T;HGVS:c.8514C&gt;T;VariantGroup:1;OriginalGene:100008982;CorrespondingGene:6696;CorrespondingSpecies:9986</infon><infon key="type">DNAMutation</infon><location offset="21811" length="11" /><text>c.8514C &gt; T</text></annotation></passage><passage><infon key="name_3">surname:Cheng;given-names:L</infon><infon key="name_2">surname:Chen;given-names:M</infon><infon key="name_1">surname:Chu;given-names:P</infon><infon key="name_0">surname:Wang;given-names:G</infon><infon key="fpage">3745</infon><infon key="issue">1</infon><infon key="pub-id_pmid">31544532</infon><infon key="year">2019</infon><infon key="source">Artif Cells Nanomed Biotechnol</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1080/21691401.2019.1666862</infon><infon key="lpage">57</infon><infon key="name_5">surname:Chen;given-names:SH</infon><infon key="name_4">surname:Zhao;given-names:C</infon><offset>21958</offset><text>Osteopontin promotes rat hepatocyte proliferation both in vitro and in vivo</text><annotation id="793"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="21958" length="11" /><text>Osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Grundner-Culemann;given-names:F</infon><infon key="name_2">surname:Scherer;given-names:N</infon><infon key="name_1">surname:Li;given-names:Y</infon><infon key="name_0">surname:Cheng;given-names:Y</infon><infon key="fpage">e1010139</infon><infon key="issue">4</infon><infon key="pub-id_pmid">35385482</infon><infon key="year">2022</infon><infon key="source">PLoS Genet</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1371/journal.pgen.1010139</infon><infon key="name_5">surname:Mishra;given-names:BH</infon><infon key="name_4">surname:Lehtimaki;given-names:T</infon><offset>22034</offset><text>Genetics of osteopontin in patients with chronic kidney disease: the German chronic kidney disease study</text><annotation id="794"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22046" length="11" /><text>osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Scott;given-names:Montgomery S</infon><infon key="name_2">surname:Othman;given-names:L</infon><infon key="name_1">surname:Lagergren;given-names:K</infon><infon key="name_0">surname:Eremo;given-names:AG</infon><infon key="fpage">1</infon><infon key="issue">1451</infon><infon key="pub-id_pmid">31913322</infon><infon key="year">2020</infon><infon key="source">Sci Rep</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1038/s41598-020-58323-w</infon><infon key="lpage">9</infon><infon key="name_5">surname:Tina;given-names:E</infon><infon key="name_4">surname:Andersson;given-names:G</infon><offset>22139</offset><text>Evaluation of SPP1/osteopontin expression as a predictor of recurrence in tamoxifen-treated breast cancer</text><annotation id="795"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22158" length="11" /><text>osteopontin</text></annotation><annotation id="796"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22153" length="4" /><text>SPP1</text></annotation></passage><passage><infon key="name_3">surname:Ostenfeld;given-names:MS</infon><infon key="name_2">surname:Jacobsen;given-names:LO</infon><infon key="name_1">surname:Buitenhuis;given-names:AJ</infon><infon key="name_0">surname:Christensen;given-names:B</infon><infon key="fpage">1</infon><infon key="issue">1166</infon><infon key="year">2023</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3390/nu15051166</infon><infon key="lpage">11</infon><infon key="name_4">surname:Sorensen;given-names:ES</infon><offset>22245</offset><text>The effect of human and bovine milk osteopontin on intestinal Caco-2 cells: a transcriptome comparison</text><annotation id="797"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22281" length="11" /><text>osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Lu;given-names:CH</infon><infon key="name_2">surname:Klement;given-names:JD</infon><infon key="name_1">surname:Poschel;given-names:D</infon><infon key="name_0">surname:Moorman;given-names:HR</infon><infon key="fpage">1</infon><infon key="issue">3379</infon><infon key="year">2020</infon><infon key="source">Cancers</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3390/cancers12113379</infon><infon key="lpage">31</infon><infon key="name_5">surname:Liu;given-names:K</infon><infon key="name_4">surname:Redd;given-names:PS</infon><offset>22348</offset><text>Osteopontin: a key regulator of tumor progression and immunomodulation</text><annotation id="798"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22348" length="11" /><text>Osteopontin</text></annotation></passage><passage><infon key="volume">59</infon><infon key="name_1">surname:Gezmen-Karadag;given-names:M</infon><infon key="section_type">REF</infon><infon key="name_0">surname:ArifIcer;given-names:M</infon><infon key="fpage">17</infon><infon key="pub-id_pmid">30003880</infon><infon key="year">2018</infon><infon key="comment">https://doi.org/10.1016/j.clinbiochem.2018.07.003</infon><infon key="source">Clin Biochem</infon><infon key="type">ref</infon><infon key="lpage">24</infon><offset>22419</offset><text>The multiple functions and mechanisms ofosteopontin</text></passage><passage><infon key="name_3">surname:Zhu;given-names:W</infon><infon key="name_2">surname:Chen;given-names:Q</infon><infon key="name_1">surname:Shao;given-names:W</infon><infon key="name_0">surname:Lin;given-names:J</infon><infon key="fpage">1785</infon><infon key="pub-id_pmid">28627641</infon><infon key="year">2017</infon><infon key="source">Mol Med Rep</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3892/mmr.2017.6774</infon><infon key="lpage">92</infon><infon key="name_5">surname:Jia;given-names:H</infon><infon key="name_4">surname:Lu;given-names:L</infon><offset>22471</offset><text>Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1</text><annotation id="799"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22471" length="11" /><text>Osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Ma;given-names:J</infon><infon key="volume">134</infon><infon key="name_2">surname:Zhang;given-names:J</infon><infon key="name_1">surname:Jiang;given-names:F</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Jin;given-names:CH</infon><infon key="issue">9</infon><infon key="year">2021</infon><infon key="comment">https://doi.org/10.1097/cm9.0000000000001519</infon><infon key="source">Chinese Med J</infon><infon key="type">ref</infon><infon key="name_4">surname:Ling;given-names:X</infon><offset>22589</offset><text>Role of osteopontin in diet-induced brown gallstone formation in rats</text><annotation id="800"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22597" length="11" /><text>osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Chen;given-names:Z</infon><infon key="name_2">surname:Shao;given-names:W</infon><infon key="name_1">surname:Lu;given-names:M</infon><infon key="name_0">surname:Lin;given-names:J</infon><infon key="fpage">1</infon><infon key="pub-id_pmid">28442746</infon><infon key="year">2016</infon><infon key="source">Sci Rep</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1038/srep30215</infon><infon key="lpage">12</infon><infon key="name_5">surname:Lu;given-names:L</infon><infon key="name_4">surname:Zhu;given-names:W</infon><offset>22659</offset><text>Osteopontin deficiency alters biliary homeostasis and protects against gallstone formation</text><annotation id="801"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="22659" length="11" /><text>Osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Zeng;given-names:L</infon><infon key="name_2">surname:Jiang;given-names:SH</infon><infon key="name_1">surname:Tang;given-names:H</infon><infon key="name_0">surname:Sun;given-names:H</infon><infon key="fpage">1886</infon><infon key="issue">15</infon><infon key="pub-id_pmid">19370788</infon><infon key="year">2009</infon><infon key="source">World J Gastroenterol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3748/wjg.15.1886</infon><infon key="lpage">91</infon><infon key="name_5">surname:Zhou;given-names:TY</infon><infon key="name_4">surname:Chen;given-names:EQ</infon><offset>22750</offset><text>Gender and metabolic differences of gallstone diseases</text></passage><passage><infon key="name_3">surname:Bilgihan;given-names:A</infon><infon key="name_2">surname:Ocalan;given-names:T</infon><infon key="name_1">surname:Tutuncu;given-names:T</infon><infon key="name_0">surname:Gunay;given-names:Y</infon><infon key="fpage">91</infon><infon key="year">2019</infon><infon key="source">Med Bull Haseki</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.4274/haseki.galenos.2019.4752</infon><infon key="lpage">7</infon><infon key="name_5">surname:Kama;given-names:NA</infon><infon key="name_4">surname:Korkmaz;given-names:G</infon><offset>22805</offset><text>Assessment of effects of thyrotoxicosis on gallstone formation in rabbits</text></passage><passage><infon key="name_3">surname:Fan;given-names:Y</infon><infon key="name_2">surname:Wu;given-names:SH</infon><infon key="name_1">surname:Zhao;given-names:J</infon><infon key="name_0">surname:Fu;given-names:B</infon><infon key="fpage">3498</infon><infon key="issue">15</infon><infon key="pub-id_pmid">34046450</infon><infon key="year">2021</infon><infon key="source">World J Clin Cases</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><infon key="comment">https://dx.doi.org/10.12998/wjcc.v9.i15.3498</infon><infon key="lpage">505</infon><offset>22879</offset><text>Cholesterol gallstones: focusing on the role of interstitial Cajal-like cells</text></passage><passage><infon key="name_2">surname:Srinivasan;given-names:K</infon><infon key="name_1">surname:Reddy;given-names:RRL</infon><infon key="name_0">surname:Shubha;given-names:MC</infon><infon key="fpage">201</infon><infon key="issue">2</infon><infon key="pub-id_pmid">21609281</infon><infon key="year">2011</infon><infon key="source">Appl Physiol Nutr Metab</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1139/h10-102</infon><infon key="lpage">9</infon><offset>22957</offset><text>Antilithogenic influence of dietary capsaicin and curcumin during experimental induction of cholesterol gallstone in mice</text></passage><passage><infon key="name_3">surname:Schauer;given-names:CH</infon><infon key="name_2">surname:Bilyy;given-names:R</infon><infon key="name_1">surname:Boeltz;given-names:S</infon><infon key="name_0">surname:Munoz;given-names:LE</infon><infon key="fpage">443</infon><infon key="pub-id_pmid">31422870</infon><infon key="year">2019</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1016/j.immuni.2019.07.002</infon><infon key="lpage">50</infon><infon key="name_5">surname:Widulin;given-names:N</infon><infon key="name_4">surname:Mahajan;given-names:A</infon><offset>23079</offset><text>Neutrophil extracellular traps initiate gallstone formation</text></passage><passage><infon key="name_2">surname:Wu;given-names:S</infon><infon key="name_1">surname:Kong;given-names:J</infon><infon key="name_0">surname:Chen;given-names:Y</infon><infon key="fpage">124</infon><infon key="issue">2</infon><infon key="pub-id_pmid">25502177</infon><infon key="year">2015</infon><infon key="source">Lab Invest</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1038/labinvest.2014.140</infon><infon key="lpage">31</infon><offset>23139</offset><text>Cholesterol gallstone disease: focusing on the role of the gallbladder</text></passage><passage><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Srivastava;given-names:A</infon><infon key="fpage">164</infon><infon key="issue">5</infon><infon key="year">2020</infon><infon key="comment">https://doi.org/10.15406/ghoa.2020.11.00434</infon><infon key="source">Gastroenterol Hepatol</infon><infon key="type">ref</infon><infon key="lpage">70</infon><offset>23210</offset><text>Evaluation of the biochemical changes in bile under the influence of the compound indigenous drug in biliary stone diseases</text></passage><passage><infon key="name_3">surname:Chen;given-names:SH</infon><infon key="name_2">surname:Li;given-names:SH</infon><infon key="name_1">surname:Zhang;given-names:Y</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chen;given-names:Q</infon><infon key="year">2019</infon><infon key="comment">https://doi.org/10.1155/2019/2536452</infon><infon key="source">Evid Based Complement Alternat Med</infon><infon key="type">ref</infon><infon key="name_5">surname:Li;given-names:C</infon><infon key="name_4">surname:Lin;given-names:X</infon><offset>23334</offset><text>Mechanisms underlying the prevention and treatment of cholelithiasis using traditional Chinese medicine</text></passage><passage><infon key="name_3">surname:Yurek;given-names:DA</infon><infon key="name_2">surname:Park;given-names:HM</infon><infon key="name_1">surname:Khalifeh-Soltani;given-names:A</infon><infon key="name_0">surname:Tharp;given-names:KM</infon><infon key="fpage">855</infon><infon key="issue">10</infon><infon key="year">2016</infon><infon key="source">Am J Physiol</infon><infon key="type">ref</infon><infon key="volume">310</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1152/ajpgi.00316.2015</infon><infon key="lpage">64</infon><infon key="name_5">surname:Wong;given-names:L</infon><infon key="name_4">surname:Falcon;given-names:A</infon><offset>23438</offset><text>Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis</text></passage><passage><infon key="name_3">surname:Park;given-names:JW</infon><infon key="name_2">surname:Kim;given-names:YR</infon><infon key="name_1">surname:Kim;given-names:MH</infon><infon key="name_0">surname:Lee;given-names:EJ</infon><infon key="fpage">1715</infon><infon key="issue">3</infon><infon key="pub-id_pmid">29286073</infon><infon key="year">2018</infon><infon key="source">Int J Mol Med</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3892/ijmm.2017.3326</infon><infon key="lpage">23</infon><infon key="name_4">surname:Park;given-names:WJ</infon><offset>23551</offset><text>Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis</text></passage><passage><infon key="name_3">surname:Ayoola;given-names:OA</infon><infon key="name_2">surname:Olabisi;given-names:OL</infon><infon key="name_1">surname:Folorunsho;given-names:AA</infon><infon key="name_0">surname:Sinbad;given-names:OO</infon><infon key="fpage">214</infon><infon key="issue">3</infon><infon key="year">2019</infon><infon key="source">J Food Sci Nutr Res</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.26502/jfsnr.2642-11000021</infon><infon key="lpage">35</infon><infon key="name_4">surname:Temitope;given-names:EJ</infon><offset>23683</offset><text>Vitamins as antioxidants</text></passage><passage><infon key="name_3">surname:Quwaydir;given-names:FA</infon><infon key="name_2">surname:Azab;given-names:AE</infon><infon key="name_1">surname:Elsayed;given-names:ASI</infon><infon key="name_0">surname:Adwas;given-names:AA</infon><infon key="fpage">43</infon><infon key="issue">1</infon><infon key="year">2019</infon><infon key="source">J Appl Biotechnol Bioeng</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.15406/jabb.2019.06.00173</infon><infon key="lpage">7</infon><offset>23708</offset><text>Oxidative stress and antioxidant mechanisms in the human body</text></passage><passage><infon key="name_1">surname:Xiao;given-names:JH</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Yu;given-names:CH</infon><infon key="year">2021</infon><infon key="comment">https://doi.org/10.1155/2021/6635460</infon><infon key="source">Oxidat Med Cell Long</infon><infon key="type">ref</infon><offset>23770</offset><text>The Keap1-Nrf2 system: a mediator between oxidative stress and aging</text></passage><passage><infon key="volume">2</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Garcia-Ruiz Fernandez-Checa;given-names:JC</infon><infon key="fpage">1425</infon><infon key="issue">12</infon><infon key="pub-id_pmid">30556032</infon><infon key="year">2018</infon><infon key="comment">https://doi.org/10.1002/hep4.1271</infon><infon key="source">Hepatol Commun</infon><infon key="type">ref</infon><infon key="lpage">39</infon><offset>23839</offset><text>Mitochondrial oxidative stress and antioxidants balance in fatty liver disease</text></passage><passage><infon key="name_3">surname:Zhang;given-names:ZJ</infon><infon key="name_2">surname:Wang;given-names:N</infon><infon key="name_1">surname:Tan;given-names:HY</infon><infon key="name_0">surname:Li;given-names:S</infon><infon key="fpage">26087</infon><infon key="issue">11</infon><infon key="pub-id_pmid">26540040</infon><infon key="year">2015</infon><infon key="source">Int J Mol Sci</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3390/ijms161125942</infon><infon key="lpage">124</infon><infon key="name_5">surname:Wong;given-names:CW</infon><infon key="name_4">surname:Lao;given-names:L</infon><offset>23918</offset><text>The role of oxidative stress and antioxidants in liver diseases</text></passage><passage><infon key="volume">8</infon><infon key="name_2">surname:Ito;given-names:T</infon><infon key="name_1">surname:Sono;given-names:Y</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ito;given-names:F</infon><infon key="fpage">1</infon><infon key="issue">72</infon><infon key="year">2019</infon><infon key="comment">https://doi.org/10.3390/antiox8030072</infon><infon key="source">Antioxidants</infon><infon key="type">ref</infon><infon key="lpage">28</infon><offset>23982</offset><text>Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation</text></passage><passage><infon key="name_3">surname:Hong;given-names:SJ</infon><infon key="name_2">surname:Hwang;given-names:MK</infon><infon key="name_1">surname:Yi;given-names:Y</infon><infon key="name_0">surname:Jeong;given-names:JH</infon><infon key="fpage">1</infon><infon key="issue">6</infon><infon key="year">2021</infon><infon key="source">Antioxidants</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3390/antiox10060869</infon><infon key="lpage">18</infon><infon key="name_5">surname:Kim;given-names:TS</infon><infon key="name_4">surname:Sohn;given-names:WM</infon><offset>24150</offset><text>The overactivation of NADPH oxidase during clonorchis sinensis infection and the exposure to N-nitroso compounds promote periductal fibrosis</text></passage><passage><infon key="name_3">surname:Wessjohann;given-names:LA</infon><infon key="name_2">surname:Lichtenfels;given-names:R</infon><infon key="name_1">surname:Rahn;given-names:J</infon><infon key="name_0">surname:Lennicke;given-names:C</infon><infon key="fpage">39</infon><infon key="pub-id_pmid">26369938</infon><infon key="year">2015</infon><infon key="source">Cell Commun Signal</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1186/s12964-015-0118-6</infon><infon key="name_4">surname:Seliger;given-names:B</infon><offset>24291</offset><text>Hydrogen peroxide - production, fate, and role in redox signaling of tumor cells</text></passage><passage><infon key="name_3">surname:Savvateeva;given-names:MV</infon><infon key="volume">17</infon><infon key="name_2">surname:Kardymon;given-names:OL</infon><infon key="name_1">surname:Kudryavtseva;given-names:AV</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Snezhkina;given-names:AV</infon><infon key="year">2019</infon><infon key="comment">https://doi.org/10.1155/2019/6175804</infon><infon key="source">Oxidat Med Cell Long</infon><infon key="type">ref</infon><infon key="name_5">surname:Krasnov;given-names:GS</infon><infon key="name_4">surname:Melnikova;given-names:NV</infon><offset>24374</offset><text>ROS generation and antioxidant defense systems in normal and malignant cells</text></passage><passage><infon key="name_3">surname:Levin;given-names:RM</infon><infon key="name_2">surname:Schuler;given-names:C</infon><infon key="name_1">surname:Leggett;given-names:RE</infon><infon key="name_0">surname:Venugopal;given-names:V</infon><infon key="fpage">749</infon><infon key="issue">6</infon><infon key="pub-id_pmid">21176282</infon><infon key="year">2010</infon><infon key="source">Int Braz J Urol</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1590/s1677-55382010000600014</infon><infon key="lpage">58</infon><offset>24451</offset><text>Effect of hydrogen peroxide on rabbit urinary bladder citrate synthase activity in the presence and absence of a grape suspension</text></passage><passage><infon key="name_3">surname:Suh;given-names:JH</infon><infon key="name_2">surname:Lee;given-names:JH</infon><infon key="name_1">surname:Chung;given-names:BCH</infon><infon key="name_0">surname:Park;given-names:BK</infon><infon key="fpage">2266</infon><infon key="issue">10</infon><infon key="pub-id_pmid">14562390</infon><infon key="year">2003</infon><infon key="source">World J Gastroenterol</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><infon key="comment">http://dx.doi.org/10.3748/wjg.v9.i10.2266</infon><infon key="lpage">9</infon><infon key="name_5">surname:Song;given-names:SY</infon><infon key="name_4">surname:Park;given-names:SW</infon><offset>24581</offset><text>Role of oxygen free radicals in patients with acute pancreatitis</text></passage><passage><infon key="name_3">surname:El-Medany;given-names:SA</infon><infon key="name_2">surname:Nada;given-names:SA</infon><infon key="name_1">surname:Abdel-Khalek;given-names:AM</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Selim;given-names:NA</infon><infon key="year">2008</infon><infon key="source">Nutrit Digest Physiol</infon><infon key="type">ref</infon><offset>24646</offset><text>Response of growing rabbits to dietary antioxidant vitamins e and C. 1. Effect on performance</text></passage><passage><infon key="name_3">surname:Mishra;given-names:JP</infon><infon key="name_2">surname:Yadav;given-names:A</infon><infon key="name_1">surname:Kumari;given-names:R</infon><infon key="name_0">surname:Yadav;given-names:A</infon><infon key="fpage">1328</infon><infon key="issue">11</infon><infon key="year">2016</infon><infon key="source">Res Environ Life Sci</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><infon key="comment">Available via </infon><infon key="lpage">31</infon><infon key="name_5">surname:Prabha;given-names:S</infon><infon key="name_4">surname:Srivatva;given-names:S</infon><offset>24740</offset><text>Antioxidants and its functions in the human body - a review</text></passage><passage><infon key="name_3">surname:Yu;given-names:DY</infon><infon key="name_2">surname:Feitelson;given-names:MA</infon><infon key="name_1">surname:Hye-Jun;given-names:Shin HJ</infon><infon key="name_0">surname:Ha;given-names:HL</infon><infon key="fpage">6035</infon><infon key="issue">48</infon><infon key="pub-id_pmid">21182217</infon><infon key="year">2010</infon><infon key="source">World J Gastroenterol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.3748/wjg.v16.i48.6035</infon><infon key="lpage">43</infon><offset>24802</offset><text>Oxidative stress and antioxidants in hepatic pathogenesis</text></passage><passage><infon key="name_3">surname:Alwahaibi;given-names:N</infon><infon key="name_2">surname:Hamid;given-names:ZA</infon><infon key="name_1">surname:Budin;given-names:SB</infon><infon key="name_0">surname:Matough;given-names:FA</infon><infon key="fpage">556</infon><infon key="issue">1</infon><infon key="year">2012</infon><infon key="source">Sultan Qaboos Univ Med J</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.12816/0003082</infon><infon key="lpage">69</infon><infon key="name_4">surname:Mohamed;given-names:J</infon><offset>24860</offset><text>The role of oxidative stress and antioxidants in diabetic complications</text></passage><passage><infon key="name_3">surname:Juvonen;given-names:P</infon><infon key="name_2">surname:Harju;given-names:J</infon><infon key="name_1">surname:Aspinen;given-names:S</infon><infon key="name_0">surname:Karkkainen;given-names:J</infon><infon key="fpage">6921</infon><infon key="issue">12</infon><infon key="pub-id_pmid">29187474</infon><infon key="year">2017</infon><infon key="source">Anticancer Res</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.21873/anticanres.12156</infon><infon key="lpage">7</infon><infon key="name_5">surname:Eskelinen;given-names:M</infon><infon key="name_4">surname:Pulkki;given-names:K</infon><offset>24932</offset><text>A randomized study with special reference to cancer patients</text></passage><passage><infon key="volume">24</infon><infon key="name_1">surname:Chandel;given-names:NS</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Schieber;given-names:M</infon><infon key="fpage">453</infon><infon key="issue">10</infon><infon key="year">2014</infon><infon key="comment">https://doi.org/10.1016/j.cub.2014.03.034</infon><infon key="source">NIH Public Access</infon><infon key="type">ref</infon><infon key="lpage">62</infon><offset>24993</offset><text>ROS function in redox signaling and oxidative stress</text></passage><passage><infon key="name_3">surname:Atamer;given-names:Y</infon><infon key="name_2">surname:Yesil;given-names:A</infon><infon key="name_1">surname:Kurdas-Ovunc;given-names:AO</infon><infon key="name_0">surname:Atamer;given-names:A</infon><infon key="fpage">66</infon><infon key="issue">1</infon><infon key="pub-id_pmid">24496161</infon><infon key="year">2014</infon><infon key="source">Saudi J Gastroenterol</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.4103/1319-3767.126325</infon><infon key="lpage">73</infon><offset>25046</offset><text>Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis</text></passage><passage><infon key="volume">11</infon><infon key="name_2">surname:Abduredha;given-names:M</infon><infon key="name_1">surname:Al-Salih;given-names:RMH</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Yousif;given-names:SY</infon><infon key="fpage">174</infon><infon key="issue">1</infon><infon key="year">2019</infon><infon key="comment">Available via </infon><infon key="source">Pharm Sci Res</infon><infon key="type">ref</infon><infon key="lpage">8</infon><offset>25158</offset><text>Effect of cholecystectomy on serum oxidative stress and nitric pre-oxide and post-operation</text></passage><passage><infon key="volume">31</infon><infon key="name_2">surname:Arguelles;given-names:S</infon><infon key="name_1">surname:Munoz;given-names:MF</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ayala;given-names:A</infon><infon key="year">2014</infon><infon key="comment">http://dx.doi.org/10.1155/2014/360438</infon><infon key="source">Oxid Med Cell Longev</infon><infon key="type">ref</infon><offset>25250</offset><text>Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal</text></passage><passage><infon key="name_3">surname:Yang;given-names:G</infon><infon key="name_2">surname:O'Brien;given-names:P</infon><infon key="name_1">surname:Tsenova;given-names:L</infon><infon key="name_0">surname:Subbian;given-names:S</infon><infon key="fpage">289</infon><infon key="pub-id_pmid">21703411</infon><infon key="year">2011</infon><infon key="source">Am J Pathol</infon><infon key="type">ref</infon><infon key="volume">179</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1016/j.ajpath.2011.03.039</infon><infon key="lpage">301</infon><infon key="name_5">surname:Peixoto;given-names:B</infon><infon key="name_4">surname:Koo;given-names:M</infon><offset>25362</offset><text>Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology</text></passage><passage><infon key="name_3">surname:Wang;given-names:L</infon><infon key="name_2">surname:Cai;given-names:D</infon><infon key="name_1">surname:Chen;given-names:J</infon><infon key="name_0">surname:Yang;given-names:L</infon><infon key="fpage">16</infon><infon key="issue">1</infon><infon key="year">2012</infon><infon key="source">Med Sci Monit</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.12659/msm.882194</infon><infon key="lpage">23</infon><infon key="name_4">surname:Zha;given-names:X</infon><offset>25515</offset><text>Osteopontin and integrin are involved in cholesterol gallstone formation</text><annotation id="802"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="25515" length="11" /><text>Osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Wang;given-names:L</infon><infon key="name_2">surname:Cai;given-names:D</infon><infon key="name_1">surname:Chen;given-names:J</infon><infon key="name_0">surname:Yang;given-names:L</infon><infon key="fpage">437</infon><infon key="pub-id_pmid">21435127</infon><infon key="year">2011</infon><infon key="source">Hepatol Res</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="section_type">REF</infon><infon key="comment">https://doi.org/10.1111/j.1872-034X.2011.00790</infon><infon key="lpage">45</infon><infon key="name_4">surname:Zha;given-names:X</infon><offset>25588</offset><text>Osteopontin plays an anti-nucleation role in cholesterol gallstone formation</text><annotation id="803"><infon key="identifier">100008982</infon><infon key="type">Gene</infon><location offset="25588" length="11" /><text>Osteopontin</text></annotation></passage><passage><infon key="name_3">surname:Zhang;given-names:J</infon><infon key="name_2">surname:Zhao;given-names:E</infon><infon key="name_1">surname:Li;given-names:ZH</infon><infon key="name_0">surname:Cui;given-names:Y</infon><infon key="fpage">593</infon><infon key="pub-id_pmid">27847447</infon><infon key="year">2012</infon><infon key="source">EXCLI J</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="comment">Available via </infon><infon key="lpage">603</infon><infon key="name_4">surname:Cui;given-names:N</infon><offset>25665</offset><text>Ursodeoxycholic acid lowers bile lithogenicity by regulating scp2 expression in rabbit cholesterol gallstone models</text></passage><passage><infon key="name_1">surname:Wu;given-names:SH</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chen;given-names:G</infon><infon key="year">2020</infon><infon key="comment">https://doi.org/10.1155/2020/1343969</infon><infon key="source">Gastroenterol Res Pract</infon><infon key="type">ref</infon><offset>25781</offset><text>Role of baicalin and liver X receptor alpha in the formation of cholesterol gallstones in mice</text></passage><relation id="R1"><infon key="score">0.9899</infon><infon key="role1">Disease|MESH:D042882</infon><infon key="role2">Gene|100008982</infon><infon key="type">Association</infon></relation></document>
</collection>